 |
|
Tumor cells that border normal tissue are told to leave
January 11, 2006The thin, single-cell boundary where a tumor meets normal tissue is the most dangerous part of a cancer according to a new study by scientists at Washington University School of Medicine in St. Louis. The researchers found that tumor cells bordering normal tissue receive signals that tell them to wander away from the tumor, allowing the cancer cells to establish deadly metastatic tumors elsewhere in the body.
The researchers say their discovery demonstrates the importance of the tumor's environment and shows more precisely how the metastatic process occurs and might be stopped. Their study appears in the January 10 issue of Developmental Cell.
"What actually kills in cancer is not the primary tumor-it's metastasis," says senior author Ross L. Cagan, Ph.D., associate professor of molecular biology and pharmacology and a researcher with the Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital. "You can't study that in a laboratory dish. You have to look at the tumor cells in their natural environment-surrounded by normal tissues."
To do this, the research team created tumors in fruit fly eyes and wings that permitted them to study the behavior of individual tumor cells.
"We found that the tumor cells in direct contact with normal cells had a different behavior than cells further inside the tumor," says lead author Marcos Vidal, Ph.D., research associate in molecular biology and pharmacology. "They were exclusively the ones that tended to leave the tissue."
The tumors were generated by turning off an inhibitor of a major oncogene called Src (pronounced sarc), making the tumor cells high in Src oncogene activity. (An oncogene is a gene that increases the malignancy of a tumor cell.) This particular genetic change is common in human breast tumors.
Boundary tumor cells were shown to lose surface proteins that attach them to other cells and stabilize their position within tissues. The study demonstrated that it was the difference in Src activity that led to the change in the attachment proteins. When a high Src cell (tumor cell) was next to a low Src cell (normal cell) the attachment proteins changed their characteristics, and the high Src cell became "unglued."
In addition, this change sent a signal that activated several other proteins in the tumor cell, one of which was an enzyme that dissolves the matrix surrounding cells. This enzyme makes it possible for a cell to move through tissues.
"Even though all the cells in the tumors we created were genetically identical, the proximity of the boundary cells to normal cells-their interaction with normal cells-made them special," Vidal says. "This is the first time the epithelial environment has been shown to play a role in metastasis."
The cells that left the fruit fly tumors eventually succumbed to the natural process of programmed cell death and were eliminated. According to Cagan, that was not unexpected.
"In a tumor, probably 99.99 percent of the border cells are raining out of the edges and dying," Cagan says. "But as oncologists have found, cancer stems from an accumulation of genetic mutations. If one of these wandering cells acquires a second mutation that prevents cell death, it could go on to establish a metastatic tumor."
Having created a model for studying metastasis of tumor cells, the research team has begun to look for ways to manipulate boundary cells to prevent their metastatic behavior. They have seen that disabling some of the genes in the pathway activated in boundary cells stops the cells from leaving the tumor.
Cagan's laboratory also has developed a robotic system for screening anticancer drugs, and they plan to use this system to look for drugs that will affect the metastatic process in their fruit fly model.
"A drug that can prevent metastasis would be an important adjunct for cancer treatments," Cagan says. "It could cut a patient's risk of having tumor cells leave the area before the primary tumor was eradicated. That's essential-metastatic cancer is far harder to treat than early-stage tumors."
Washington University School of Medicine
To do this, the research team created tumors in fruit fly eyes and wings that permitted them to study the behavior of individual tumor cells.
"We found that the tumor cells in direct contact with normal cells had a different behavior than cells further inside the tumor," says lead author Marcos Vidal, Ph.D., research associate in molecular biology and pharmacology. "They were exclusively the ones that tended to leave the tissue."
The tumors were generated by turning off an inhibitor of a major oncogene called Src (pronounced sarc), making the tumor cells high in Src oncogene activity. (An oncogene is a gene that increases the malignancy of a tumor cell.) This particular genetic change is common in human breast tumors.
Boundary tumor cells were shown to lose surface proteins that attach them to other cells and stabilize their position within tissues. The study demonstrated that it was the difference in Src activity that led to the change in the attachment proteins. When a high Src cell (tumor cell) was next to a low Src cell (normal cell) the attachment proteins changed their characteristics, and the high Src cell became "unglued."
In addition, this change sent a signal that activated several other proteins in the tumor cell, one of which was an enzyme that dissolves the matrix surrounding cells. This enzyme makes it possible for a cell to move through tissues.
"Even though all the cells in the tumors we created were genetically identical, the proximity of the boundary cells to normal cells-their interaction with normal cells-made them special," Vidal says. "This is the first time the epithelial environment has been shown to play a role in metastasis."
The cells that left the fruit fly tumors eventually succumbed to the natural process of programmed cell death and were eliminated. According to Cagan, that was not unexpected.
"In a tumor, probably 99.99 percent of the border cells are raining out of the edges and dying," Cagan says. "But as oncologists have found, cancer stems from an accumulation of genetic mutations. If one of these wandering cells acquires a second mutation that prevents cell death, it could go on to establish a metastatic tumor."
Having created a model for studying metastasis of tumor cells, the research team has begun to look for ways to manipulate boundary cells to prevent their metastatic behavior. They have seen that disabling some of the genes in the pathway activated in boundary cells stops the cells from leaving the tumor.
Cagan's laboratory also has developed a robotic system for screening anticancer drugs, and they plan to use this system to look for drugs that will affect the metastatic process in their fruit fly model.
"A drug that can prevent metastasis would be an important adjunct for cancer treatments," Cagan says. "It could cut a patient's risk of having tumor cells leave the area before the primary tumor was eradicated. That's essential-metastatic cancer is far harder to treat than early-stage tumors."
Washington University School of Medicine
Tumor Cell Current Events and Tumor Cell News RSSResearch reveals lipids' unexpected role in triggering death of brain cells
The lipid that accumulates in brain cells of individuals with an inherited enzyme disorder also drives the cell death that is a hallmark of the disease, according to new research led by St. Jude Children's Research Hospital investigators.
New Notre Dame study provides insights into the molecular basis of tumor cell behavior
A new study by a team of researchers led by Crislyn D'Souza-Schorey, associate professor of biological sciences at the University of Notre Dame, sheds light on the molecular basis by which tumor cells modulate their surroundings to favor cancer progression.
Outfoxing pox: Developing a new class of vaccine candidates
In the annals of medicine, Edward Jenner's 1796 vaccination of a young boy against smallpox, using fluid from cowpox blisters, remains a landmark case. In a new study, Kathryn Sykes, a researcher at Arizona State University's Biodesign Institute and her colleagues have taken a fresh look at cowpox.
M. D. Anderson examines use of toad venom in cancer treatment
Huachansu, a Chinese medicine that comes from the dried venom secreted by the skin glands of toads, has tolerable toxicity levels, even at doses eight times those normally administered, and may slow disease progression in some cancer patients, say researchers from The University of Texas M. D. Anderson Cancer Center.
Novel 'on-off switch' mechanism stops cancer in its tracks
A tiny bit of genetic material with no previously known function may hold the key to stopping the spread of cancer, researchers at Yale School of Medicine and Sichuan University in Chengdu, China report in two papers in the September 7-11 issue of Proceedings of the National Academy of Sciences.
Lung cancer suppresses miR-200 to invade and spread
Primary lung cancer shifts to metastatic disease by suppressing a family of small molecules that normally locks the tumor in a noninvasive state, researchers at The University of Texas M. D. Anderson Cancer Center report in the Sept. 15 edition of Genes and Development.
New method monitors early sign of oxidative stress in cancer
The growth of cancerous tumors is fueled, at least in part, by the buildup of free radicals-highly reactive oxygen-containing molecules.
Mayo Clinic Researchers Find That Protein Believed to Protect Against Cancer Has a Mr. Hyde Side
In a biological rendition of fiction's Strange Case of Dr. Jekyll and Mr. Hyde, researchers from the Mayo Clinic campus in Florida and Harvard Medical School have found that a protein thought to protect against cancer development can actually spur the spread of tumors.
U-Iowa improves delivery of cancer-fighting molecules
Small interfering RNA (siRNA), a type of genetic material, can block potentially harmful activity in cells, such as tumor cell growth. But delivering siRNA successfully to specific cells without adversely affecting other cells has been challenging.
First compound that specifically kills cancer stem cells found
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all.
More Tumor Cell Current Events and Tumor Cell News Articles
 |
Cancer Cell Culture: Methods and Protocols (Methods in Molecular Medicine) by Simon P. Langdon (Editor) Western General Hospital, Edinburgh, UK. Describes easy-to-follow methods for guiding researchers on new techniques in cell and molecular biology of cancer, Features the basic concept of cancer cell culture and general techniques used in many cell culture facilities. Also covers the isolation of specific cancer cell types. For researchers. |
 |
Cure Ovarian Germ Cell Tumor Long Sleeve T-shirt Large White by Shop Zeus |
 |
Fight Against Germ Cell Tumor Keychain by Design a Product LLC Text on keychain: Fight Against Germ Cell Tumor * Durable acrylic key chain is crystal-clear and double-sided so the artwork or message is seen twice. * Sturdy metal ring holds your keys securely. * Full color printed images or messages are included. * If you have new ideas or need help selecting text for your custom keychains please contact us. * Size: 2 1/8" x 3 1/2" (Approx. business card) |
 |
Mobile Starring: Keith Allen, Julie Graham, Michael Kitchen, Samantha Bond, Jamie Draven Directed By: Stuart Orme Conspiracy, betrayal, and revenge in the global telecom industry Someone is blowing up mobile-phone towers across England. Messages scrawled in blood-red paint at the scenes proclaim that mobile phones are the instruments of the devil. What’s more, a gunman -- or gunmen -- is shooting cell phone users in mid-conversation. Baffled police investigators scramble to avert public panic. In four interlocking parts, this tense drama peels back the layers of a terrorist conspiracy, gradually revealing the evil at its core. We follow three characters -- a disgraced telecom executive (Michael Kitchen, Foyle’s War), a bitter ex-soldier (Jamie Draven, Billy Elliot), and a disgruntled engineer (Neil Fitzmaurice, Going Off Big Time) -- all united by circumstance or collusion. In a style... |
 |
Maximum Intenational Maximize Graviola 750, 750mg Graviola, 100 Veggie Caps by Maximum International Having attracted worldwide interest as an inhibitor of malignant cell growth, this remarkable Amazonian herb has been studied in more than 20 laboratory tests for its anti-tumor and cell protective qualities. The best Graviola on the market. Maximum Int'l. is the company with the most potent products available. Lab tested to make sure the ingredients are of the most superior quality and highes quality raw materials available. This product is manufactured in an FDA inspected and GMP certified facility. Quality is guaranteed. |
 |
Germ Cell Tumors (ACS ATLAS OF CLINICAL ONCOLOGY) by Derek Raghavan (Author) Crafted as a descriptive and visual text, Germ Cell Tumors features definitive reviews of the biology, diagnosis, and management of germ cell tumors. Incorporating extensive illustrations and tables, this book reviews the progress that has been made in the curative therapy of germ cell tumors over the past 25 years, progress that has lead to the positioning of germ cell tumor therapy as the paradigm of curative treatment in adult solid tumors. Most of the work has been produced on a multidisciplinary basis, emphasizing the use of different diagnostic, laboratory, imaging, and management tools. In addition to a scientific and clinical review, this book features a series of detailed discussions on the psychosocial issues, patient support, and management of the occasional problem cases that... |
 |
Cancer Stem Cells: Novel Concepts and Prospects for Tumor Therapy (Ernst Schering Foundation Symposium Proceedings) by O.D. Wiestler (Editor), B. Haendler (Editor), D. Mumberg (Editor) Cancer stem cells have originally been identified in leukemia and later in several solid tumor types. They have very different properties from the bulk of the tumor, as they divide much more slowly and have very efficient drug- resistance mechanisms. Current treatments might largely spare cancer stem cells, thus leading to tumor recurrence and metastasis. The recent identification of growth and differentiation pathways responsible for cancer stem cell proliferation and survival will help in the discovery identification of novel therapeutic targets. Developing selective drugs against cancer stem cells offers great therapeutic opportunities but also provides for major challenges regarding preclinical models, therapeutic windows, and clinical study end points. |
 |
Fight Against Extracranial Germ Cell Tumor Long Sleeve T-shirt Large White by Shop Zeus |
 |
Organic Noni Juice, Morinda Citrifolia, Unflavored, Vegetarian 16 oz by Dynamic Health Laboratories by Dynamic Health It is believed that the Noni (Morinda Citrifolia) tree originated in Southeast Asia about two thousand years ago. Since that time, the precious fruit of the Noni tree has been distributed throughout the islands of the South Pacific, as the tree will only thrive in the delicate ecosystem of the tropics. The great gifts of the Noni fruit are well-known in tropical cultures. Noni Juice (Morinda Citrifolia) has traditionally been used to cleanse and purify the entire system, as a defense against illness, to aid digestion, to heal abrasions, to reduce swelling and inflammation and reduce pain. Dynamic Health Laboratories, Inc. offers a variety of Noni formulas so that you can choose the one that's right for you. Usage: Take 2 tablespoons (1fl.oz) daily on an empty stomach, preferably in the... |
 |
Atlas of Human Tumor Cell Lines by Robert K.M. Hay (Editor), Jae-Gahb Park (Editor), Adi Gazdar (Editor) Human tumor cells in culture are valuable for studying cancer causes and properties. This convenient reference provides useful information for cancer researchers on commonly used, established tumor cell lines of the major human organ systems. Atlas of Human Tumor Cell Lines includes data about morphological, metabolic, genetic, and growth characteristics of human tumor cells, with morphological characteristics presented in more than 250 photomicrographs. It also contains information for establishing and maintaining human tumor cell lines in culture, and each chapter covers future perspectives. * * Covers well-characterized tumor cell lines from the major human organ systems * Presents over 250 photomicrographs, both phase-contrast... |
| © 2009 BrightSurf.com |